Many breast cancer patients don't get treatment for heart problems

Only a third of older breast cancer patients saw a cardiologist within 90 days of developing heart problems, in a study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.

Breast cancer patients with heart problems who saw a were more likely to receive standard therapy for their than those who did not see a heart specialist, the study found.

"The majority of older women who develop heart problems after their breast cancer therapy aren't treated by a cardiologist, and they had lower quality of care," said Jersey Chen, M.D., M.P.H., lead author of the study and a research scientist and cardiologist at Kaiser Permanente in Rockville, Maryland. "This suggests that this is an important area for oncologists and cardiologists to collaborate."

For the study, researchers used a Medicare-linked database to identify women older than 65 who were diagnosed in 2000-09 with stage I-III breast cancer and received cancer treatments that previously had been linked to heart problems.

The study tracked which patients developed cardiomyopathy or heart failure. Cardiomyopathy is a weakening of the heart and its ability to pump blood. Heart failure occurs when the weakened heart causes symptoms such as fatigue and shortness of breath.

Among 8,400 treated with either chemotherapy drugs called anthracyclines or a targeted therapy called trastuzumab, 1,028—about 12 percent—developed heart problems within three years, and 345 (34 percent) saw a cardiologist within 90 days of their heart diagnosis. Women with heart failure after cancer treatment were more likely to be treated with standard medications if seen by a cardiologist compared with those who did not see a cardiologist.

"The bottom line is, if you have and you're treated with anthracyclines or trastuzumab, you should know they have side effects," Chen said. "And if you have symptoms of heart problems like shortness of breath or swelling in the feet or legs, seek attention quickly, preferably with doctors familiar and comfortable with treating heart failure after cancer therapy."

"Many cancer patients who develop heart failure or cardiomyopathy aren't getting the necessary medications, regardless of whether they're seen by cardiologists," he said. "So there is work to be done to improve care for all women with cardiac complications after ."

Using 2006-11 data from Medicare's Part D drug benefit, the study found that 60 percent of patients with who saw a cardiologist received ACE inhibitors or angiotensin receptor blockers, versus 44 percent of those who didn't see a cardiologist. For beta-blockers, the figures were 40 percent versus 24 percent. Those drugs are the mainstay of treatment for heart failure, Chen said.

People with other cancers—especially if they're older or have many other health problems—should also be vigilant for symptoms if they receive anthracyclines or trastuzumab, Chen said.

add to favorites email to friend print save as pdf

Related Stories

More heart problems with two chemo drugs for breast cancer

Aug 30, 2012

Women who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health ...

Recommended for you

NT-proBNP modestly improves CVD risk prediction in women

16 hours ago

(HealthDay)—N-terminal pro-B-type natriuretic peptide (NT-proBNP) modestly improves cardiovascular disease (CVD) risk prediction for women, according to a study published in the Oct. 28 issue of the Journal of ...

User comments